All news

Berkshire trims Nucor stake, forgoing $313 million

Alpha Vantage · Benzinga · · AI-summarised by FinFlash

Berkshire Hathaway, under successor Greg Abel, sold more than 6.6 million Nucor shares across the first and second quarters of 2026, forgoing over $313 million in gains based on current prices. The reduction marks a shift in strategy as Abel reassesses positions inherited from Warren Buffett's portfolio. Nucor trades at $251.41 against an analyst target of $283.94, implying 12.9% upside, with ratings of 13 buy, 3 hold and 1 sell.

Read original source

NUE company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.